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1. Introduction  
Spontaneous sinus rhythm recovery occurs in not more than 10% of patients with 
preoperative atrial fibrillation and mitral valve disease who undergo mitral valve surgery 
(Kernis et al, 2004). In a recent review Lee et al (2009) reported that less than 20% of patients 
with permanent atrial fibrillation undergoing surgery without treatment of atrial fibrillation 
were in sinus rhythm at 6-8 months from operation. Persistence of atrial fibrillation (AF) is 
associated with a decreased exercise tolerance, an increased risk of systemic embolization 
(Reston & Shuahaiber, 2005) and an higher long-term mortality (Khargi et al 2005). 
Moreover 15% of patients in sinus rhythm before surgery are discharged in atrial fibrillation 
after treatment of mitral valve disease. At multivariate analysis an enlarged left atrium is 
associated with an increase risk of development of AF.  
The surgical treatment of AF was proposed by James Cox in the1980s and evolved into the 
Maze III procedure (Cox et al, 1991). The aim of the intervention was to create numerous 
atrial surgical incisions that form a maze-like pattern, with the scar tissue providing a 
conduction block to interrupt propagation of the arrhythmia from sites of electrical 
instability and favouring the conduction from sinus node to atrio-ventricular node. The 
procedure involves surgical encircling of pulmonary veins at their entry in left atrium. A 
lesion between an inferior pulmonary vein and the mitral annulus, and a lesion joining the 
coronary sinus and the inferior vena cava are usually added to block other trigger zones, in 
particular in patients with permanent atrial fibrillation The left atrial appendages is excised 
or closed to prevent thromboembolism in the event of postoperative AF. 
The surgical treatment proposed by Cox has been mainly used in patients with other heart 
disease with indication to surgery, however it was used also in patients with invalidating 
“lone atrial fibrillation “ not responsive to pharmacological treatment.  
Despite an high success rate, from 70% to 90% in relation to population treated, surgical 
Maze procedure has an elevated technical difficulty, prolongs significantly the times of 
cardiopulmonary by-pass, increases the risk of post-operatory bleeding and has a not 
negligible risk of mortality. The need for permanent pacing is close to 6%.  
Sinus rhythm recovery allows the maintenance of atrial mechanic activity and prevents the 
development or worsening of tricuspid regurgitation (Je et al, 2008).   
Preoperatory duration of atrial fibrillation and left atrial volume were independent factors 
related to sinus rhythm recovery (Benussi et al, 2002; Beukema et al, 2005; Chan et al, 2005).  
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In the following years, due to the complexity of the “cut and saw” Maze procedure, the 
research was directed to create the maze pattern with energy ablation rather than incisions  
(Benussi et al, 2001). These methods have simplified the procedure and increased its 
application. Energy sources used for intraoperative ablation include cryotherapy, 
radiofrequency, microwave, laser, and ultrasound. 
Radiofrequency probes may be unipolar or bipolar (Williams et al, 2001; Gaynor et al, 2004). 
The main limitation of monopolar probes is the high probability to not obtain transmural 
lesions. Bipolar probes have an higher chance to obtain transmural lesions and a reduced 
risk of damaging adjacent structures such as the esophagus. (Bugge et al, 2005; Benussi et al, 
2005). Moreover have been introduced devices for epicardial treatment which allows 
treatment for example in patients undergoing off-pump coronary revascularization. 
Irrigated radiofrequency probes have greater efficiency because the cooling effect on the 
surface of the tissue drives the focus of energy deeper into the tissue and prevents char 
accumulation on the surface. Radiofrequency treatment of atrial fibrillation usually prolongs 
the times of the intervention by no more of 20 minutes.  
More recently bipolar radiofrequency probes have been introduced to treat “lone atrial 
fibrillation “ through a mini invasive bilateral thoracotomy , thus avoiding the need for 
sternotomy and related complications (Wolf et al , 2005). Preliminary results are similar to 
that obtained with the traditional surgical approach.  
Microwave energy creates deeper lesions than does radiofrequency energy in a similar 
length of time and may have more potential for epicardial application. Laser and ultrasound 
energy are still relatively new energy sources, but both may produce transmural lesions 
even through epicardial fat (Saltman et al, 2003).  
2. Literature review  
In patients undergoing combined mitral valve and Cox maze surgery, Cox et al (2004) 
reported 98% cure of AF, Prasad et al (2003) observed a greater than 90% freedom from AF 
in patients having a Cox maze procedure with concomitant surgery. In contrast, others have 
used a classic cut-and-sew technique and reported less success. Raanani et al ( 2001) 
recorded sinus rhythm in only 75% of patients a mean of 26 months after Cox maze and 
mitral valve surgery, which is similar to the Mayo Clinic experience of 74% freedom from 
AF at 2 years ( Handa et al ,1999; Shaff et al 2000).  
The use of RF energy for the creation of the atrial lesions of the Cox maze procedure was 
associated with significantly less freedom from AF both at hospital discharge and at follow-
up (Stulak et al 2007).  
The differences of the long-term success rate could be influenced other than by the 
differences among intraoperative variables, mainly by preoperative variables, such as 
concomitant valvular surgery and rheumatic valvular heart disease. 
The surgical results of the maze procedure for AF associated with rheumatic mitral valve 
disease have been known to be less effective than for lone or non-rheumatic AF (Raanani et al, 
2001). Few clinical studies in the literature compared the results of concomitant AF maze in 
open heart surgery with those of a concurrent control arm (that is leaving the AF untreated). A 
control is important to eliminate confounding variables that may influence results of the maze 
procedure and the determination of clinical outcomes. Absence of a control arm also does not 
allow discernment of the absolute effect of the maze surgery because we cannot know how 
many of the patients would convert to sinus rhythm spontaneously. 
Wogk and Mak (2006) examited the results of seven matched-controlled and four 
randomized trials of Maze procedure associated with concomitant mitral valve surgery. In 
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the matched-controlled studies freedom from AF was 77% to 95% in the maze group versus 
4% to 53% in the control group at 2 to 8 years of follow-up. In matched-controlled studies 
12-lead electrocardiography was used for rhythm evaluation. The four randomized studies 
reported a 78% to 88% freedom from AF in the maze group versus 20% to 40% in the control 
group at 1- to 1.5-year follow-up 
About 20—30% of the patients who underwent maze procedures have shown recurrence of 
AF during the follow-up periods, and there are few reports showing mid- to long-term 
results and reporting predictors of the maze failure.  
Je et al, (2008) showed that preoperative size of the LA larger than 60 mm, cardiothoracic 
ratio over 60%, fine AF wave in preoperative ECG, no early sinus restoration and SSA were 
found as independent predictors of maze failure in mid-term follow-up period at 
multivariate analysis. Patients with left atrial dimension 50 mm or greater had almost twice 
probability of experience late recurrence of AF.  
Besides the acute end point (for example, PV isolation, demonstration of bidirectional block 
of linear lesions, non-inducibility of AF, etc), the more important result of any ablation 
strategy is the clinical efficacy in restoring SR without the need for further antiarrhythmic 
medication. However, comparison of clinical success has been hampered by the absence of a 
clear AF classification, adequate reporting of underlying cardiac conditions (such as 
coronary artery disease, heart failure, etc), and the use of symptomatic only follow-up. 
“Rhythm at last follow-up” may underestimate the recurrence of atrial arrhythmias in the 
follow-up period, and thus overestimate the success of the procedure. In a consent statement 
(Calkins et al, 2007) a minimum of sequential Holter recordings is advised, with more 
stringent recommendations for prospective trials (for example, 7 days of Holter recording or 
even implantable loop recording). 
Finally a “prophylactic” maze procedure has been proposed for patients with preoperative 
sinus rhythm and a dilated left atrium undergoing surgery for mitral valve disease. The 
altered atrial tissue in these patients represents an arrhythmogenic substrate, with an high 
risk (approximately 40%) for the development of postoperative AF even after correction of 
the mitral valve disease. Clearly, the risks and benefits should be weighed before an 
additional procedure is performed, which carries intraoperative and long-term (Saad et al, 
2003) adjuntive risks other the need of PPM implantation (new permanent pacemakers are 
required in 10% to 15% of patients) (Gillinov et al, 2004). The indication in almost all was 
bradycardia due to sinus node dysfunction. Technical modifications to the original Cox-
maze operation may however reduce injury to the sinoatrial node. 
2.1 Personal experience  
In our Department the fist Cox maze radiofrequency (RF) ablation was performed in 2002 in 
one patient undergoing mitral valve repair. Since then at least 350 procedures, initially with 
monopolar thereafter with bipolar probes, have been performed, usually in association with 
mitral valve surgery but also with more complex interventions. In present  paper we report 
the results of monopolar radiofrequency ablation in patients with atrial fibrillation 
undergoing mitral valve surgery. 
At present, long terms results of AF radiofrequency ablation associated with mitral valve 
surgery are poorly defined in literature not allowing the definition of classes of 
recommendation and levels of evidence concerning the utility and efficacy of the procedure 
(Padalinam et al., 2005). 
In present investigation we evaluated: overall mortality; cause and time of death ; incidence 
of stroke; maintenance of sinus rhythm; persistence of sinus rhythm during follow-up; 
eventual relapse of AF or the onset of other types of arrhythmias; the necessity of permanent 
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pacing after the procedure; further hospitalization due to cardiac complications; . We even 
evaluated the relationship between several clinical and echocardiographic parameters and 
long term clinical outcome. 
2.1.1 Material and methods  
Patient population. 
From 1/1/2002 to 31/12/2007, 173 patients with AF and mitral valve disease underwent 
monopolar radiofrequency ablation procedure, associated with mitral valve surgery in the 
heart surgery Deparment of the Azienda Ospedaliera Universitaria di Careggi (AOUC).  
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Fig. 1. Monopolar radiofrequency ablation at Florence Heart Surgery Department  
In the study were included 101 men and 72 women, with a mean age of 67 +/- 9 years.  
81.7% were in permanent AF (mean duration 38 +/- 43 months) while 18.3% suffered from 
paroxysmal AF. 
A careful clinical evaluation was performed before surgery in order to establish time of 
onset of AF and NHYA functional class. Electrocardiographic examination was performed 
to confirm the presence of the arrhythmia.  
All patients underwent transthoracic echocardiography using a 2.5 and 3.5 MHz probe 
(Sequoia C256 Acuson Siemens Mount View, California). Parameter measured were : left 
atrium M-mode AP diameter (mm) and 2D area (cm2) and right atrium 2D area (cm2) from 
four chamber projection, left ventricular ejection fraction (LVEF)- average value of three 
measurements. End-diastolic and end-systolic images were synchronized on ECG tracings.  
Pulmonary systolic pressure (PAP) was calculated adding RV/RA pressure gradient to 
estimated right atrial pressure.  
For statistical analysis were recorded: 
- the surgical procedure (valve replacement with mechanical or biologic valve vs. mitral 
valve repair; associated surgical procedures). 
- associated tricuspid valve repair  
- need for electrical cardioversion before discharge.    
- need for permanent pacing  
- ECG rhythm at the time of discharge. After surgery patients were evaluated after the 
first and sixth months and later once a year. At every visit we performed a clinical, 
electrocardiographic and echocardiographic examination. In addition to previously 
reported parameters in patients in sinus rhythm right and left E and A waves 
amplitude and E/A ratio were measured to evaluate atrial mechanical activity.  
The study was terminated on December 31 2010. Overall duration of follow-up has been 
1743 +/- 845 days. 
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Maze Procedure  
The Medtronic Cardioblate surgical ablation system consists of a power generator and a 
pen. The pen is a handheld, unipolar RF ablation device. The electrode tip is irrigated with 
saline that cools the tissue and provides a low-impedance path, which allows creation of 
deeper lesions with less damage to the surrounding tissue The patient is grounded by an 
indifferent electrode applied to the skin. After median sternotomy, cardiopulmonary bypass 
(CPB) was established with bicaval and aortic cannulation under moderate hypothermia 
(32°C); myocardial protection was assured by antegrade crystalloid cardioplegia. The aorta 
was cross-clamped and the heart was arrested with cold cardioplegic solution. Access to the 
inside of the left atrium was gained through a standard atriotomy in the interatrial groove, 
as for a mitral valve (MV) procedure. After the LAA was excised and sutured, an ablation 
line from the LAA to the left superior pulmonary vein was created. In addition to the 
incision in the interatrial groove, isolation of the right pulmonary veins was completed by a 
circular ablation line. The left pulmonary veins were encircled. Two linear ablations were 
performed endocardially. The first connected the two encirclings on the posterosuperior 
atrial wall. This lesion was kept cranial, opposite the transverse sinus, to prevent any 
possible damage to the esophagus. The last ablation connected the left appendage to the 
posterior aspect of the mitral annulus. To protect the circumflex artery from heat trauma, the 
lesion line reached the mitral posterior annulus far from the antero-lateral commisure 
(figure 2). The transesophageal echocardiographic probe was removed during the ablation 
to prevent any  
 
 
Fig. 2. Modified RF Maze procedure – schematic representation of ablation lines 
damage by the transmission of the heat waves to the esophagus. The mitral valve procedure 
was completed and the left atriotomy was sutured in the standard fashion.  
Postoperative Management 
Antiarrhythmic prophylaxis was carried out on a routine basis. Amiodarone, intravenous 
bolus of 300 mg, followed by a continuous infusion of 1,200 mg/24 h f was administered in 
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the first 48 hours; thereafter were prescribed 200 mg every 8 hours until discharge, followed 
by a maintenance regimen of 200 mg/day for 1 month. Recurrences of the arrhythmia after 
surgery were treated by optimizing the medical treatment. Patients who had AF despite 
optimal medical therapy had at least one attempt of external cardioversion by biphasic DC-
shock Successful treatment of the arrhythmia was defined as the absence of refractory AF in 
patients with chronic AF before operation and absence of any episode of sustained 
arrhythmia in patients with paroxysmal AF preoperatively. Six months after surgery, oral 
anticoagulants were discontinued in patients with stable SR and with documented atrial 
contraction after mitral valve repair or replacement with a biological prosthesis. 
2.1.2 Statistical analysis  
Data are presented as means +/- SDs for continuous variables and as percentages for 
categorical variables. Continuous variables were compared through the use of Student’s 2 
tailed unpaired-sample test. Categorical variables were compared using the chi-square test 
or Fisher’s exact test if appropriate.Kaplan-Meier curves were used for the survival analysis. 
Differences between groups were compared using Log-Rank test. 
A probability value < 0.05 was considered significant. Statistical analysis were performed 
with SPSS 18.0 software (SPSS, Inc., Chicago, IL, USA).  
2.1.3 Results  
Four patients died in the immediate postoperative period (2,3%). One patient died for 
cerebral hemorrhage, one for myocardial infarction, the other 2 for septic shock. 
Therefore 169 patients, 99 men and 70 women, were included in the study. Clinical and 
echocardiographic characteristics are reported in table 1.  
 
Sex (M/F) 99/70 
Age (years ) 67 +/-9 
AF duration before surgery (months ) 38 +/- 43 
Left ventricular EF (%) 52 +/- 10 
Left atrium diameter (mm) 53.6 +/- 7 
Left atrium area (cm2) 32.5 +/- 10 
Right atrium area (cm2) 22.3 +/- 6.7 
Systolic pulmonary pressure (mmHg) 45 +/- 15 
NHYA class  3 +/- 0.55 
Table 1. Clinical and echocardiographic characteristics 
 
 N° % 
Mitral valve prolapse 48 28.6 
Rheumatic mitral valve disease  57 33.9 
Mitro-aortic rheumatic valve disease  25 15 
Ischemic mitral regurgitation  20 11.9 
Mitral regurgitation associated with DCM  6 3.5 
Other  12 7.1 
Table 2. Etiology of mitral valve disease. DCM= dilated cardiomyopathy 
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Rheumatic mitral valve disease, alone or associated with aortic valve disease, was the most 
frequent indication to surgery (73/169), followed by mitral valve prolapse (table 2) 
Mitral valve repair was performed in 46 %. In combined mitro-aortic valve disease, aortic 
valve replacement was combined with mitral valve replacement in more than 60% of 
patients and with mitral valve repair in the remaining cases. Twenty (12%) patients 
underwent associated CABG (figure 2). 
                  
 
(a) 
 
(b) 
Fig. 3. a) Main surgical procedure (%) b) associated surgery (n°).  
26/169 (15%) patients underwent tricuspid valve repair for severe tricuspid regurgitation 
most (>85%) according to Kay technique. At the time of surgery almost 80% of patients had 
severe functional impairment (III-IV NHYA class).  
 
NYHA class before surgery  % 
I 0 0 
II 27 16 
III 116 69 
IV 24 15 
Table 3. Functional NYHA class before surgery  
Rhythm analysis. 
119/169 subjects ( 70%) were in sinus rhythm at hospital discharge , while sinus rhythm was 
present in 100 at the end of follow up period. Atrial fibrillation was never resolved in 39. 
During the period of follow up 42% of patients has been in stable sinus rhythm, while 34 % 
had at least one symptomatic AF recurrence. 7,8% developed arrhythmias different from AF. 
 
Stable sinus rhythm N (%) AF recurrence N (%) Permanent AFN (%) 
72 (42%) 58 (34%) 39 (24%) 
Table 4. Number an percentage of patients with stable sinus rhythm (SR), with AF 
recurrence and persistent atrial fibrillation (AF) 
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Stable sinus 
rhythm
AF
recurrences
Permanent 
AF
P 
Age  
(years ) 
68.1 +/- 9.6 67.7 +/- 9.8 71.5 +/- 8 0.0494 
Left atrium diameter 
(mm) 
51.6 +/- 6.6 54.2 +/- 8.3 55.5 +/- 8.2 <0.0001 
Left atrium area 
(cm2) 
30.4 +/- 7.2 32.8 +/- 8.5 36.9 +/- 14.5 <0.0001 
Right atrium area
(cm2) 
20.6 +/- 4.5 22.2 +/- 6.3 23.7 +/- 6.2 <0.0159 
Systolic PAP  
(mmHg) 
41.2 +/- 12.8 44.7 +/- 15.3 45.3 +/- 15.8 <0.0001 
Electrical CV before 
discharge  
(%) 
9.5 20.5 28.6 0.0092 
Hospitalizations
(%) 
17.4 48.4 30.8 <0.0001 
Table 5. Comparison of baseline clinical and echocardiographic parameters in patients with 
stable sinus rhythm (SR), with AF recurrence and permanent atrial fibrillation (AF) 
On average AF recurrence occurred 750 days after surgery.  
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Fig. 4. Survival free from AF recurrences in patients with SR at hospital discharge  
In table 5 are reported the clinical and echocardiographic characteristics of the three groups 
of patients (stable sinus rhythm; AF recurrences; permanent AF) at enrolment.  
Patients who were in chronic AF were on average older (3 years) than those who never had 
AF recurrences or who remained in permanent sinus rhythm (p=0,0494; figure 5). 
www.intechopen.com
 
Treatment of Atrial Fibrillation in Patients Undergoing Mitral Valve Surgery 
 
315 
 
 
 
Fig. 5. Baseline mean age in patients in stable sinus rhythm (SR), with AF recurrence and 
permanent atrial fibrillation (AF) 
 
 
  
 
Fig. 6. Baseline left atrium diameter (left) and area (right) in patients in stable sinus rhythm 
(SR), with AF recurrence and permanent atrial fibrillation (AF) 
Left atrium diameter (p=0,0001; figure 6,a), left atrium area (p<0,0001; figure 6,b) and right 
atrium area (p<0,0159) resulted significantly lower in patients with permanent sinus rhythm 
in comparison with the other two groups. 
Estimated systolic pulmonary artery pressure was higher in patient with AF recurrences or 
in chronic AF than in those with permanent sinus rhythm (p<0,0001; figure 7). 
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Fig. 7. Baseline systolic pulmonary artery pressure in patients in stable sinus rhythm (SR), 
with AF recurrence and permanent atrial fibrillation (AF) 
The number of patients who needed electrical cardioversion before hospital discharge was 
significantly lower in the group with stable sinus rhythm than in the other groups (p= 
0.005). Twenty-three patients underwent definitive cardiac electrical stimulation. In 6 
patients permanent pacing was needed during hospitalization. In 17 a pace maker was 
implanted during follow-up period. 3,5% had at least one cerebrovascular accident during 
the postoperative period.  
Baseline mean NYHA class was 2.96 in SR and 3.3 in AF patients. At follow-up a significant 
improvement was found in SR patients (average NYHA class 1.31 vs 2.33, p<0.003).  
 
 
NYHA class 
before surgery 
NYHA class 
at follow-up 
I 0 47 
II 27 68 
III 116 31 
IV 24 5 
Table 6. NYHA functional class before surgery and at follow-up  
33,9% underwent hospitalization due to cardiac cause during the follow up period. 
Hospitalization percentage was almost twofold in patients with chronic AF compared to 
patients in sinus rhythm (p<0.0001). 
Mortality  
At the end of the average five years follow-up period survival was 86.4%. 
Twenty three patients died: in 62% death was due cardiac causes, in the other 38% the cause 
of death was not cardiac or unknown. Death occurred on overage occurred days after 
surgery. 
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Fig. 8. Actuarial survival curve in patients undergoing RF ablation of AF associated with 
mitral valve surgery.  
Deceased patients were about 5 years older than survivors (mean age of 67 years vs 72 years 
in the group of deceased patients, p=0.005). 
Mortality was higher in men than in women (23% vs 9%).  
Time free from AF recurrences, right and left atrial are were related to higher mortality.  
 
 Survived dead P 
AF duration before surgery (months) 37 +/-48 46 +/-46 0.31 
Time free from AF recurrence (day after 
surgery)  
937 +/-738 422 +/-485 0.015 
LVEF (%) 52+/- 9 52 +/- 10 0.83 
Left atrium diameter (mm) 53,4 +/-9 56 +/- 11 0.17 
Left atrium area (cm2) 31,1 +/- 7 38 +/- 10 0.0116 
Right atrium area (cm2) 21,6 +/- 6 24,5 +/- 9 0.0128 
Systolic pulmonary pressure (mmHg) 44 +/- 14 48 +/- 17 0.26 
Table 7. Comparison of clinical and echocardiographic parameters between patients 
survived and went to death  
Overall long-term mortality was higher in patients with rheumatic than in those suffering 
from mitral valve prolapse  (table 8).  
 
Etiology Mortality n (%) 
Mitral valve prolapse 4 (8.8%) 
Rheumatic mitral valve disease  13 (22%) 
Mitro-aortic rheumatic valve disease  2 (8%) 
Ischemic mitral regurgitation  3 (15%) 
Mitral regurgitation associated with DCM  1 (16%) 
Other  0 (0%) 
Table 8. Relationship between mortality and etiology of mitral valve disease 
Relationship between mortality and type of procedure performed is illustrated in table 9: 
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Intervention Mortality n (%) 
Mitral valve replacement (mechanical) 5 (20%) 
Mitral valve replacement (biological) 5 (17%) 
Mitral valve repair 7 (12%) 
Mitral valve replacement/repair plus aortic valve replacement 1 ( 4%) 
Mitral valve repair plus CABG 3 (16%) 
Mitral valve replacement plus CABG 2 (40%) 
Other  0 (0%) 
Table 9. Relationship between mortality and type of intervention performed  
Tricuspid valve repair was significantly associated with an higher mortality: it was 
performed in 40% of deceased patients in comparison to 12% of survivors (p= 0.005). 
Preoperative NHYA class was not statistically related to survival. The percentage of patients 
in advanced NHYA class (III-IV) was similar in the two groups (82% of survivors vs 91 % of 
patients went to death). 
 
NYHA class Survived (%) Dead (%) 
I 0 0
II 25 2
III 102 15
IV 19 6
Table 10. Relationship between mortality and NYHA class before surgery  
Failure to restore sinus rhythm with RF ablation was related to a worse prognosis. Mortality 
at five years was 30% in patients discharged form hospital in AF in comparison to 10% of 
those discharged in sinus rhythm.  
Moreover survival was higher in patients with stable sinus rhythm during follow up respect 
to patients with recurrences and finally patients with permanent AF (table 10). 
Figure 9 shows the survival curves in patients with persistent sinus rhythm, patients with 
AF recurrences and patients with permanent AF (Log Rank test-p=0.0022). 
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Fig. 9. Kaplan-Meier survival curves in in patients in stable sinus rhythm (SR), with AF 
recurrence and permanent atrial fibrillation (AF) 
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3. Conclusion  
The ideal goal of AF surgery is a safe, simple, effective, and tailored approach to eradicate 
the most likely mechanism of AF. New technologies in AF surgery have evolved in creating 
the lines of block faster, easier, safer, and transmurally.  
The merits of various alternative energy sources used to create the lines of block of the maze 
are subject of debate. But more important AF surgery should be able to demonstrate that 
mantainance of SR is associated with improved clinical outcomes. Results from our 
investigation support the hypothesis that in patients remained in sinus rhythm after RF 
ablation not only the quality of life is improved, as demonstrated by the lower NYHA 
functional class in patients with stable SR in comparison to patients with permanent AF,  but 
also significantly affects mortality. Properly conducted, larger, randomized studies with 
adequate follow-up however are needed to determine the true impact of concomitant maze 
surgery on clinical outcomes. 
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